LIGAND PHARMACEUTICALS INC GNRAL CONT RT
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for LIGAND PHARMACEUTICALS INC GNRAL CONT RT COM, CUSIP 53220K199.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for LIGAND PHARMACEUTICALS INC GNRAL CONT RT COM, CUSIP 53220K199.